Cancer control and prevention: Nutrition and epigenetics

Current Opinion in Clinical Nutrition and Metabolic Care

Volumn 16, Issue 4, 2013, Pages 376-384

  Verma, Mukesh ^a  

^a NATIONAL CANCER INSTITUTE   (United States)

Author keywords

Bioactive food components; Biomarker; Cancer; Epigenetics; Prevention

Indexed keywords

5 AZA 2' DEOXYCYTIDINE; AZACITIDINE; BENZAMIDE DERIVATIVE; BIOLOGICAL MARKER; DNA METHYLTRANSFERASE; FREE RADICAL; HISTONE DEACETYLASE INHIBITOR; HYDROXAMIC ACID; ISETHIONIC ACID; METHYLTRANSFERASE INHIBITOR; POLYPHENOL; RETINOIC ACID; RETINOID; SELENIUM; SHORT CHAIN FATTY ACID; TETRAPEPTIDE; ZEBULARINE;

ANTINEOPLASTIC ACTIVITY; CALORIC INTAKE; CANCER CONTROL; CANCER PREVENTION; DEACETYLATION; EPIGENETICS; GENE EXPRESSION; GENE INSERTION; GENE MUTATION; GENOME; GENOMIC INSTABILITY; HISTONE ACETYLATION; HUMAN; METHYLATION; MYELODYSPLASTIC SYNDROME; NUCLEOTIDE SEQUENCE; NUTRIENT; NUTRITION; PHENOTYPE; REVIEW; SINGLE NUCLEOTIDE POLYMORPHISM;

DIET; EPIGENESIS, GENETIC; GENE EXPRESSION PROFILING; GENETIC MARKERS; HUMANS; MICRONUTRIENTS; NEOPLASMS; NUTRITIONAL STATUS; POLYPHENOLS;

EID: 84880331190     PISSN: 13631950     EISSN: 14736519     Source Type: Journal    
DOI: 10.1097/MCO.0b013e328361dc70     Document Type: Review

References (133)

1. Teegarden D, Romieu I, Lelievre SA. Redefining the impact of nutrition on breast cancer incidence:is epigenetics involved? Nutr Res Rev 2012; 25:68-95.
2. Gerhauser C. Cancer chemoprevention and nutri-epigenetics:state of the art and future challenges. Top Curr Chem 2012; 329:73-132.
3. Sinha R, Cross AJ, Daniel CR, et al. Caffeinated and decaffeinated coffee and tea intakes and risk of colorectal cancer in a large prospective study. Am J Clin Nutr 2012; 96:374-381.
4. Banque M, Raido B, Masuet C, Ramon JM. Food groups and nutrient intake and risk of colorectal cancer:A hospital-based case-control study in Spain. Nutr Cancer 2012; 64:386-392.
5. Cai Y, Lv J, Zhang W, Zhang L. Dietary exposure estimates of 16 polycyclic aromatic hydrocarbons (PAHs) in Xuanwei and Fuyuan, counties in a high lung cancer incidence area in China. J Environ Monit 2012; 14:886-892.
6. Balansky R, Ganchev G, Iltcheva M, et al. Inhibition of lung tumor development by berry extracts in mice exposed to cigarette smoke. Int J Cancer 2012; 131:1991-1997.
7. Abbaoui B, Riedl KM, Ralston RA, et al. Inhibition of bladder cancer by broccoli isothiocyanates sulforaphane and erucin:characterization, metabolism, and interconversion. Mol Nutr Food Res 2012; 56:1675-1687.
8. Ganesh B, Sushama S, Monika S, Suvarna P. A case-control study of risk factors for lung cancer in Mumbai, India. Asian Pac J Cancer Prev 2011; 12:357-362.
9. Hardell S, Tilander H, Welfinger-Smith G, et al. Levels of polychlorinated biphenyls (PCBs) and three organochlorine pesticides in fish from the Aleutian Islands of Alaska. PloS one 2010; 5:e12396.
10. Trasande L, Attina TM, Blustein J. Association between urinary bisphenol A concentration and obesity prevalence in children and adolescents. JAMA 2012; 308:1113-1121.
11. Vanden Berghe W. Epigenetic impact of dietary polyphenols in cancer chemoprevention:lifelong remodeling of our epigenomes. Pharmacol Res 2012; 65:565-576.
12. Su LJ. Diet, epigenetics, and cancer. Methods Mol Biol 2012; 863:377-393.
13. Attig L, Gabory A, Junien C. Nutritional developmental epigenomics:immediate and long-lasting effects. Proc Nutr Soc 2010; 69:221-231.
14. Verma M. Cancer control and prevention by nutrition and epigenetic approaches. Antioxid Redox Signal 2012; 17:355-364.
15. Ong TP, Moreno FS, Ross SA. Targeting the epigenome with bioactive food components for cancer prevention. J Nutrigenet Nutrigenomics 2011; 4:275-292.
16. Huang J, Plass C, Gerhauser C. Cancer chemoprevention by targeting the epigenome. Curr Drug Targets 2011; 12:1925-1956.
17. Burdge GC, Hoile SP, Lillycrop KA. Epigenetics:are there implications for personalised nutrition? Curr Opin Clin Nutr Metab 2012; 15:442-447.
18. Issa JP, Just W. Epigenetics. FEBS Lett 2011; 585:1993.
19. Boumber Y, Issa JP. Epigenetics in cancer:what's the future? Oncology (Williston Park) 2011; 25:220-226; 8.
20. Ross SA, Davis CD. MicroRNA, nutrition, and cancer prevention. Adv Nutr 2011; 2:472-485.
21. Su Z.Y., Shu L., Khor T.O., et al., A perspective on dietary phytochemicals and cancer chemoprevention:oxidative stress, Nrf2, and epigenomics, Top Curr Chem 2012 329 133-162.
22. Davis CD, Emenaker NJ, Milner JA. Cellular proliferation, apoptosis and angiogenesis:molecular targets for nutritional preemption of cancer. Semin Oncol 2010; 37:243-257.
23. Davis CD, Milner JA. Molecular targets for nutritional preemption of cancer. Curr Cancer Drug Targets 2007; 7:410-415.
24. Dashwood RH, Myzak MC, Ho E. Dietary HDAC inhibitors:time to rethink weak ligands in cancer chemoprevention? Carcinogenesis 2006; 27:344-349.
25. Link A, Balaguer F, Goel A. Cancer chemoprevention by dietary polyphenols:promising role for epigenetics. Biochem Pharmacol 2010; 80:1771-1792.
26. Knackstedt RW, Moseley VR, Wargovich MJ. Epigenetic mechanisms underlying diet-sourced compounds in the prevention and treatment of gastrointestinal cancer. Anticancer Agents Med Chem 2012; 12:1203-1210.
27. Chen J, Xu X. Diet, epigenetic, and cancer prevention. Adv Genet 2010; 71:237-255.
28. Lee SA, Kim YM, Kwak TK, et al. The extracellular loop 2 of TM4SF5 inhibits integrin alpha2 on hepatocytes under collagen type I environment. Carcinogenesis 2009; 30:1872-1879.
29. Ho E, Beaver LM, Williams DE, Dashwood RH. Dietary factors and epigenetic regulation for prostate cancer prevention. Adv Nutr 2011; 2:497-510.
30. Ito K, Lim S, Caramori G, et al. A molecular mechanism of action of theophylline:induction of histone deacetylase activity to decrease inflammatory gene expression. Proc Natl Acad SciU S A 2002; 99:8921-8926.
31. Andujar I, Recio MC, Giner RM, Rios JL. Cocoa polyphenols and their potential benefits for human health. Oxidative medicine and cellular longevity 2012; 2012:906252.
32. Periasamy VS, Alshatwi AA. Tea polyphenols modulate antioxidant redox system on Cisplatin-induced ROS generation in a human breast cancer cell. Basic Clin Pharmacol Toxicol 2012. 10.1111/bcpt.12035. [Epub ahead of print].
33. Basak S, Pookot D, Noonan EJ, Dahiya R. Genistein down-regulates androgen receptor by modulating HDAC6-Hsp90 chaperone function.Mol Cancer Ther 2008; 7:3195-3202.
34. Bontempo P, Mita L, Miceli M, et al. Feijoa sellowiana derived natural Flavone exerts anticancer action displaying HDAC inhibitory activities. Int J Biochem Cell Biol 2007; 39:1902-1914.
35. Myzak MC, Ho E, Dashwood RH. Dietary agents as histone deacetylase inhibitors. Mol Carcinog 2006; 45:443-446.
36. Myzak MC, Dashwood RH. Histone deacetylases as targets for dietary cancer preventive agents:lessons learned with butyrate, diallyl disulfide, and sulforaphane. Curr Drug Targets 2006; 7:443-452.
37. Lea MA, Randolph VM. Induction of histone acetylation in rat liver and hepatoma by organosulfur compounds including diallyl disulfide. Anticancer Res 2001; 21:2841-2845.
38. Myzak MC, Dashwood WM, Orner GA, et al. Sulforaphane inhibits histone deacetylase in vivo and suppresses tumorigenesis in Apc-minus mice. FASEB J 2006; 20:506-508.
39. Myzak MC, Hardin K, Wang R, et al. Sulforaphane inhibits histone deacetylase activity in BPH-1, LnCaP and PC-3 prostate epithelial cells. Carcinogenesis 2006; 27:811-819.
40. King-Batoon A, Leszczynska JM, Klein CB. Modulation of gene methylation by genistein or lycopene in breast cancer cells. Environ Mol Mutagen 2008; 49:36-45.
41. Kune G, Watson L. Colorectal cancer protective effects and the dietary micronutrients folate, methionine, vitamins B6, B12, C, E, selenium, and lycopene. Nutr Cancer 2006; 56:11-21.
42. Pallas M, Verdaguer E, Tajes M, et al. Modulation of sirtuins:new targets for antiageing. Recent Pat CNS Drug Discov 2008; 3:61-69.
43. Stefanska B, Karlic H, Varga F, et al. Epigenetic mechanisms in anticancer actions of bioactive food components-The implications in cancer prevention. B J Pharmacol 2012; 167:279-297.
44. Choi SW, Friso S. Epigenetics:A new bridge between nutrition and health. Adv Nutr 2010; 1:8-16.
45. Lee KW, Bode AM, Dong Z. Molecular targets of phytochemicals for cancer prevention. Nat Rev Cancer 2011; 11:211-218.
46. Aggarwal BB, Prasad S, Reuter S, et al. Identification of novel anti-inflammatory agents from Ayurvedic medicine for prevention of chronic diseases:'reverse pharmacology' and 'bedside to bench' approach. Curr Drug Targets 2011; 12:1595-1653.
47. Kim SP, Kang MY, Nam SH, Friedman M. Dietary rice bran component gamma-oryzanol inhibits tumor growth in tumor-bearing mice. Mol Nutr Food Res 2012; 56:935-944.
48. Kyritsis AP, Bondy ML, Levin VA. Modulation of glioma risk and progression by dietary nutrients and antiinflammatory agents. Nutr Cancer 2011; 63:174-184.
49. Burdge GC, Lillycrop KA. Nutrition, epigenetics, and developmental plasticity:implications for understanding human disease. Annu Rev Nutr 2010; 30:315-339.
50. Li Y, Tollefsbol TO. Impact on DNA methylation in cancer prevention and therapy by bioactive dietary components. Curr Med Chem 2010; 17:2141-2151.
51. Barrera LN, Cassidy A, Johnson IT, et al. Epigenetic and antioxidant effects of dietary isothiocyanates and selenium:potential implications for cancer chemoprevention. Proc Nutr Soc 2012; 71:237-245.
52. Lim U, Song MA. Dietary and lifestyle factors of DNA methylation. Methods Mol Biol 2012; 863:359-376.
53. Hardy TM, Tollefsbol TO. Epigenetic diet:impact on the epigenome and cancer. Epigenomics 2011; 3:503-518.
54. Khan SI, Aumsuwan P, Khan IA, et al. Epigenetic events associated with breast cancer and their prevention by dietary components targeting the epigenome. Chem Res Toxicol 2012; 25:61-73
55. Wang H, Bian S, Yang CS. Green tea polyphenol EGCG suppresses lung cancer cell growth through upregulating miR-210 expression caused by stabilizing HIF-1alpha. Carcinogenesis 2011; 32:1881-1889.
56. Nandakumar V, Vaid M, Katiyar SK. (-)-Epigallocatechin-3-gallate reactivates silenced tumor suppressor genes, Cip1/p21 and p16INK4a, by reducing DNA methylation and increasing histones acetylation in human skin cancer cells. Carcinogenesis 2011; 32:537-544.
57. Fang M, Chen D, Yang CS. Dietary polyphenols may affect DNA methylation. J Nutr 2007; 137:223S-228S.
58. Majid S, Dar AA, Ahmad AE, et al. BTG3 tumor suppressor gene promoter demethylation, histone modification and cell cycle arrest by genistein in renal cancer. Carcinogenesis 2009; 30:662-670.
59. Liu Z, Xie Z, Jones W, et al. Curcumin is a potent DNA hypomethylation agent. Bioorganic Med Chem Lett 2009; 19:706-709.
60. Papoutsis AJ, Lamore SD, Wondrak GT, et al. Resveratrol prevents epigenetic silencing of BRCA-1 by the aromatic hydrocarbon receptor in human breast cancer cells. J Nutr 2010; 140:1607-1614.
61. Lee WJ, Zhu BT. Inhibition of DNA methylation by caffeic acid and chlorogenic acid, two common catechol-containing coffee polyphenols. Carcinogenesis 2006; 27:269-277.
62. Rajendran P, Ho E, Williams DE, Dashwood RH. Dietary phytochemicals, HDAC inhibition, and DNA damage/repair defects in cancer cells. Clin Epigenetics 2011; 3:4.
63. Clarke JD, Hsu A, Yu Z, et al. Differential effects of sulforaphane on histone deacetylases, cell cycle arrest and apoptosis in normal prostate cells versus hyperplastic and cancerous prostate cells. Mol Nutr Food Res 2011; 55:999-1009.
64. Rajendran P, Delage B, Dashwood WM, et al. Histone deacetylase turnover and recovery in sulforaphane-treated colon cancer cells:competing actions of 14-3-3 and Pin1 in HDAC3/SMRT corepressor complex dissociation/ reassembly. Mol Cancer 2011; 10:68.
65. Wang LG, Liu XM, Fang Y, et al. De-repression of the p21 promoter in prostate cancer cells by an isothiocyanate via inhibition of HDACs and c-Myc. Int J Oncol 2008; 33:375-380.
66. Hayes JD, Kelleher MO, Eggleston IM. The cancer chemopreventive actions of phytochemicals derived from glucosinolates. Eur J Nutr 2008; 47 (Suppl 2):73-88.
67. Kassam S, Goenaga-Infante H, Maharaj L, et al. Methylseleninic acid inhibits HDAC activity in diffuse large B-cell lymphoma cell lines. Cancer Chemother Pharmacol 2011; 68:815-821.
68. Ferguson LR, Karunasinghe N, Zhu S, Wang AH. Selenium and its' role in the maintenance of genomic stability. Mutat Res 2012; 733:100-110.
69. Williams CD, Satia JA, Adair LS, et al. Antioxidant and DNA methylationrelated nutrients and risk of distal colorectal cancer. Cancer Causes Control 2010; 21:1171-1181.
70. Xiang N, Zhao R, Song G, Zhong W. Selenite reactivates silenced genes by modifying DNA methylation and histones in prostate cancer cells. Carcinogenesis 2008; 29:2175-2181.
71. Lim JS, Park SH, Jang KL. All-trans retinoic acid induces cellular senescence by up-regulating levels of p16 and p21 via promoter hypomethylation. Biochem Biophys Res Commun 2011; 412:500-505.
72. Kashyap V, Gudas LJ. Epigenetic regulatory mechanisms distinguish retinoic acid-mediated transcriptional responses in stem cells and fibroblasts. J Biol Chem 2010; 285:14534-14548.
73. Raffoux E, Cras A, Recher C, et al. Phase 2 clinical trial of 5-azacitidine, valproic acid, and all-trans retinoic acid in patients with high-risk acute myeloid leukemia or myelodysplastic syndrome. Oncotarget 2010; 1:34-42.
74. Savickiene J, Treigyte G, Jonusiene V, et al. Epigenetic changes by zebularine leading to enhanced differentiation of human promyelocytic leukemia NB4 and KG1 cells. Mol Cell Biochem 2012; 359:245-261.
75. Wolffe AP. Inheritance of chromatin states. Dev Genet 1994; 15:463-470.
76. van Bemmel D, Lenz P, Liao LM, et al. Correlation of LINE-1 methylation levels in patient-matched buffy coat, serum, buccal cell, and bladder tumor tissue DNA samples. Cancer Epidemiol, Biomarkers Prev 2012; 21:1143-1148.
77. Nikolaidis G, Raji OY, Markopoulou S, et al. DNA methylation biomarkers offer improved diagnostic efficiency in lung cancer. Cancer Res 2012.
78. van der Drift MA, Prinsen CF, Knuiman GJ, et al. Diagnosing peripheral lung cancer:the additional value of the Ras-association domain family 1A gene methylation and Kirsten rat sarcoma 2 viral oncogene homolog mutation analyses in washings in nondiagnostic bronchoscopy. Chest 2012; 141:169-175.
79. Teplyuk NM, Mollenhauer B, Gabriely G, et al. MicroRNAs in cerebrospinal fluid identify glioblastoma and metastatic brain cancers and reflect disease activity. NeuroOncol 2012; 14:689-700.
80. Kim GE, Kweon SS, Lee JS, et al. Quantitative assessment of DNA methylation for the detection of cervical and endometrial adenocarcinomas in liquid-based cytology specimens. Anal Quant Cytol Histol 2012; 34:195-203.
81. Sun C, Reimers LL, Burk RD. Methylation of HPV16 genome CpG sites is associated with cervix precancer and cancer. Gynecol Oncol 2011; 121:59-63.
82. Antill YC, Mitchell G, Johnson SA, et al. Gene methylation in breast ductal fluid from BRCA1 and BRCA2 mutation carriers. Cancer Epidemiol, Biomarkers Prev 2010; 19:265-274.
83. Locke I, Kote-Jarai Z, Fackler MJ, et al. Gene promoter hypermethylation in ductal lavage fluid from healthy BRCA gene mutation carriers and mutationnegative controls. Breast Cancer Res 2007; 9:R20.
84. Browne EP, Punska EC, Lenington S, et al. Increased promoter methylation in exfoliated breast epithelial cells in women with a previous breast biopsy. Epigenetics 2011; 6:1425-1435.
85. de Freitas Cordeiro-Silva M, Oliveira ZF, de Podesta JR, et al. Methylation analysis of cancer-related genes in nonneoplastic cells from patients with oral squamous cell carcinoma. Mol Biol Rep 2011; 38:5435-5441.
86. Roos PH, Jakubowski N. Methods for the discovery of low-abundance biomarkers for urinary bladder cancer in biological fluids. Bioanalysis 2010; 2:295-309.
87. Wong CM, Anderton DL, Smith-Schneider S, et al. Quantitative analysis of promoter methylation in exfoliated epithelial cells isolated from breast milk of healthy women. Epigenetics 2010; 5:645-655.
88. Stidley CA, Picchi MA, Leng S, et al. Multivitamins, folate, and green vegetables protect against gene promoter methylation in the aerodigestive tract of smokers. Cancer Res 2010; 70:568-574.
89. Negraes PD, Favaro FP, Camargo JL, et al. DNA methylation patterns in bladder cancer and washing cell sediments:A perspective for tumor recurrence detection. BMC Cancer 2008; 8:238.
90. Muretto P, Ruzzo A, Pizzagalli F, et al. Endogastric capsule for E-cadherin gene (CDH1) promoter hypermethylation assessment in DNA from gastric juice of diffuse gastric cancer patients. Ann Oncol 2008; 19:516-519.
91. Ohtsubo K, Watanabe H, Yao F, et al. Preproenkephalin hypermethylation in the pure pancreatic juice compared with p53 mutation in the diagnosis of pancreatic carcinoma. J Gastroenterol 2006; 41:791-797.
92. Ohtsubo K, Watanabe H, Okada G, et al. A case of pancreatic cancer with formation of a mass mimicking alcoholic or autoimmune pancreatitis in a young man. Possibility of diagnosis by hypermethylation of pure pancreatic juice. JOP 2008; 9:37-45.
93. Dokras A, Coffin J, Field L, et al. Epigenetic regulation of maspin expression in the human placenta. Mol Hum Reprod 2006; 12:611-617.
94. Gimenez J, Montgiraud C, Oriol G, et al. Comparative methylation of ERVWE1/syncytin-1 and other human endogenous retrovirus LTRs in placenta tissues. DNA Res 2009; 16:195-211.
95. Guilleret I, Osterheld MC, Braunschweig R, et al. Imprinting of tumorsuppressor genes in human placenta. Epigenetics 2009; 4:62-68.
96. Wong NC, Novakovic B, Weinrich B, et al. Methylation of the adenomatous polyposis coli (APC) gene in human placenta and hypermethylation in choriocarcinoma cells. Cancer Lett 2008; 268:56-62.
97. Wang Y, Zheng D, Tan Q, et al. Nanopore-based detection of circulating microRNAs in lung cancer patients. Nat Nanotechnol 2011; 6:668-674.
98. Vinci S, Gelmini S, Pratesi N, et al. Genetic variants in miR-146a, miR-149, miR-196a2, miR-499 and their influence on relative expression in lung cancers. Clin Chem Lab Med 2011; 49:2073-2080.
99. Botana-Rial M, de Chiara L, Valverde D, et al. Prognostic value of aberrant hypermethylation in pleural effusion of lung adenocarcinoma. Cancer Biol Ther 2012; 13.
100. Fujii M, Fujimoto N, Hiraki A, et al. Aberrant DNA methylation profile in pleural fluid for differential diagnosis of malignant pleural mesothelioma. Cancer Sci 2012; 103:510-514.
101. Kaur J, Demokan S, Tripathi SC, et al. Promoter hypermethylation in Indian primary oral squamous cell carcinoma. Int J Cancer 2010; 127:2367-2373.
102. Pattani KM, Zhang Z, Demokan S, et al. Endothelin receptor type B gene promoter hypermethylation in salivary rinses is independently associated with risk of oral cavity cancer and premalignancy. Cancer Prev Res (Phila) 2010; 3:1093-1103.
103. Park IS, Chang X, Loyo M, et al. Characterization of the methylation patterns in human papillomavirus type 16 viral DNA in head and neck cancers. Cancer Prev Res (Phila) 2011; 4:207-217.
104. Liu Y, Zhou ZT, He QB, Jiang WW. DAPK promoter hypermethylation in tissues and body fluids of oral precancer patients. Med Oncol 2012; 29:729-733.
105. Tessema M, Klinge DM, Yingling CM, et al. Re-expression of CXCL14, a common target for epigenetic silencing in lung cancer, induces tumor necrosis. Oncogene 2010; 29:5159-5170.
106. Hubers AJ, Heideman DA, Herder GJ, et al. Prolonged sampling of spontaneous sputum improves sensitivity of hypermethylation analysis for lung cancer. J Clin Patho 2012; 65:541-545.
107. Kato I, Badsha KZ, Land S, et al. DNA/RNA markers for colorectal cancer risk in preserved stool specimens:A pilot study. Tumori 2009; 95:753-761.
108. Hayatsu H. Re:Analysis of fecal DNA methylation to detect gastrointestinal neoplasia. J Natl Cancer Inst 2010; 102:830.
109. Nagasaka T, Tanaka N, Cullings HM, et al. Analysis of fecal DNA methylation to detect gastrointestinal neoplasia. J Natl Cancer Inst 2009; 101:1244-1258.
110. Ahmed FE, Vos P, iJames S, et al. Transcriptomic molecular markers for screening human colon cancer in stool and tissue. Cancer Genomics Proteomics 2007; 4:1-20.
111. Stewart GD, Van Neste L, Delvenne P, et al. Clinical utility of an epigenetic assay to detect occult prostate cancer in histopathologically negative biopsies:Results of the MATLOC Study. J Urol 2013; 189:1117-1122.
112. Poeta ML, Massi E, Parrella P, et al. Aberrant promoter methylation of beta-1,4 galactosyltransferase 1 as potential cancer-specific biomarker of colorectal tumors. Genes, Chromosomes Cancer 2012; 51:1133-1143.
113. Rogenhofer S, Miersch H, Goke F et al. Histone methylation defines an epigenetic entity in penile squamous cell carcinoma. J Urol 2012.
114. Asangani IA, Harms PW, Dodson L, et al. Genetic and epigenetic loss of microRNA-31 leads to feed-forward expression of EZH2 in melanoma. Oncotarget 2012; 3:1011-1025.
115. Das BC, Zhao X, Tang XY, Yang F. Design, synthesis and biological study of pinacolyl boronate-substituted stilbenes as novel lipogenic inhibitors. Bioorg Med Chem Lett 2011; 21:5638-5641.
116. Arab K, Smith LT, Gast A, et al. Epigenetic deregulation of TCF21 inhibits metastasis suppressor KISS1 in metastatic melanoma. Carcinogenesis 2011; 32:1467-1473.
117. Reinert T, Modin C, Castano FM, et al. Comprehensive genome methylation analysis in bladder cancer:identification and validation of novel methylated genes and application of these as urinary tumor markers. Clin Cancer Res 2011; 17:5582-5592.
118. Zwart W, Theodorou V, Kok M, et al. Oestrogen receptor-co-factor- chromatin specificity in the transcriptional regulation of breast cancer. EMBO J 2011; 30:4764-4776.
119. Enroth S, Rada-Iglesisas A, Andersson R, et al. Cancer associated epigenetic transitions identified by genome-wide histone methylation binding profiles in human colorectal cancer samples and paired normal mucosa. BMC Cancer 2011; 11:450.
120. Reid JF, Sokolova V, Zoni E, et al. miRNA profiling in colorectal cancer highlights miR-1 involvement in MET-dependent proliferation. Mol Cancer Res 2012; 10:504-515.
121. Lyng MB, Laenkholm AV, Sokilde R, et al. Global microRNA expression profiling of high-risk ER+ breast cancers from patients receiving adjuvant tamoxifen mono-therapy:A DBCG study. PloS one 2012; 7:e36170.
122. Hafez MM, Hassan ZK, Zekri AR, et al. MicroRNAs and metastasis-related gene expression in Egyptian breast cancer patients. Asian Pac J Cancer Prev 2012; 13:591-598.
123. Verma M. Epigenetic biomarkers in cancer epidemiology. Methods Mol Biol 2012; 863:467-480.
124. Khare S, Verma M. Epigenetics of colon cancer. Methods Mol Biol 2012; 863:177-185.
125. Chung W, Bondaruk J, Jelinek J, et al. Detection of bladder cancer using novel DNA methylation biomarkers in urine sediments. Cancer Epidemiol, Biomarkers Prev 2011; 20:1483-1491.
126. Li LY, Yu HY, Lin N, et al. Preparation, characterization, and photoelectric properties of an electrostatically self-assembled film based on tungstophosphoric acid and a binuclear Ru(II) complex. J Nanosci Nanotechnol 2011; 11:4089-4096.
127. Colacino JA, Arthur AE, Dolinoy DC, et al. Pretreatment dietary intake is associated with tumor suppressor DNA methylation in head and neck squamous cell carcinomas. Epigenetics 2012; 7:883-891.
128. Chaturvedi AK, Engels EA, Pfeiffer RM, et al. Human papillomavirus and rising oropharyngeal cancer incidence in the United States. J Clin Oncol 2011; 29:4294-4301.
129. Maxwell JH, Kumar B, Feng FY, et al. Tobacco use in human papillomaviruspositive advanced oropharynx cancer patients related to increased risk of distant metastases and tumor recurrence. Clin Cancer Res 2010; 16:1226-1235.
130. Miller A, Chen J, Takasuka TE, et al. Proliferating cell nuclear antigen (PCNA) is required for cell cycle-regulated silent chromatin on replicated and nonreplicated genes. J Biol Chem 2010; 285:35142-35154.
131. Abad PC, Lewis J, Mian IS, et al. NuMA influences higher order chromatin organization in human mammary epithelium. Mol Biol Cell 2007; 18:348-361.
132. Vasanthi D, Mishra RK. Epigenetic regulation of genes during development:A conserved theme from flies to mammals. J Genet Genomics 2008; 35:413-429.
133. Esteller M. Cancer, epigenetics and the Nobel Prizes. Mol Oncol 2012; 6:565-566. 134. Esteller M. Cancer epigenetics for the 21st century:what's next? Genes Cancer 2011; 2:604-606.